Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BELLUS Health Inc BLUSD


Primary Symbol: T.BLU

BELLUS Health Inc. is a clinical-stage biopharmaceutical company developing therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. The Company's lead product candidate, BLU-5937, which is a selective, small molecule antagonist of the P2X3 receptor, as an oral therapy to reduce cough frequency in RCC patients. The Company has completed the BLUEPRINT clinical trial, a Phase II trial evaluating BLU-5937 in patients with chronic pruritus associated with AD. The Company is focused on initiating Phase III program. The Company is exploring the use of BLU-5937 in other patient populations experiencing cough hypersensitivity as well as other P2X3-related hypersensitization conditions.


TSX:BLU - Post by User

Bullboard Posts
Comment by webpiloton Dec 21, 2010 12:16pm
638 Views
Post# 17876465

RE: RE: RE: Today's resistence.

RE: RE: RE: Today's resistence.Plenty of potential news.  For instance, Vivimind is awaiting a decision for rights to distribute in the US, a citizens petition to be exact.  A partner will be announced for distribution in Canada, and additional partnerships from around the world for Vivimind.  More news about Kiacta which has a very high probability of getting FDA approval.  News regarding P-III for NRM8499 a huge drug for Alzheimer's.

BTW, Vivimind is the only clinical product that has an impact on the brain in a very positive way, it prevents the atrophy of the hippocampus.  It actually works as proven by MRI studies, unlike any other drug including those approved by the FDA that do not work as admitted by the National Institutes of Health of the US.  Just check that web site to understand that these approved drugs actually do very little.
Bullboard Posts